These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11894369)

  • 41. [The individualized interdisciplinary intervention plan : helping resilience?].
    Jamet C; Herniotte C
    Rech Soins Infirm; 2005 Sep; (82):62-70. PubMed ID: 16231615
    [No Abstract]   [Full Text] [Related]  

  • 42. Classification of scleroderma.
    Jablońska S
    Clin Dermatol; 1994; 12(2):225-8. PubMed ID: 8076259
    [No Abstract]   [Full Text] [Related]  

  • 43. Scleroderma prevalence: demographic variations in a population-based sample.
    Bernatsky S; Joseph L; Pineau CA; Belisle P; Hudson M; Clarke AE
    Arthritis Rheum; 2009 Mar; 61(3):400-4. PubMed ID: 19248123
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidemiology and pathogenesis of scleroderma.
    Chen K; See A; Shumack S
    Australas J Dermatol; 2003 Feb; 44(1):1-7; quiz 8-9. PubMed ID: 12581091
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Age-sex aspects of distribution of children with scleroderma according to clinical forms].
    Popik GS
    Pediatriia; 1990; (12):81-2. PubMed ID: 2075074
    [No Abstract]   [Full Text] [Related]  

  • 46. [Microcirculation in children with scleroderma].
    Vlasova TM
    Pediatriia; 1987; (12):25-7. PubMed ID: 3444693
    [No Abstract]   [Full Text] [Related]  

  • 47. Relationship between occupational risk factors and severity markers of systemic sclerosis.
    Magnant J; de Monte M; Guilmot JL; Lasfargues G; Diot P; Asquier E; Degenne D; Boissinot E; Diot E
    J Rheumatol; 2005 Sep; 32(9):1713-8. PubMed ID: 16142866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An international survey of developing classification criteria for juvenile dermatomyositis-scleroderma overlap.
    Khaosut P; Pilkington C; Wedderburn LR; Compeyrot-Lacassagne S
    Rheumatology (Oxford); 2019 Nov; 58(11):2062-2064. PubMed ID: 31199482
    [No Abstract]   [Full Text] [Related]  

  • 49. Unmet needs following hospitalization with heart failure: implications for clinical assessment and program planning.
    Davidson PM; Cockburn J; Newton PJ
    J Cardiovasc Nurs; 2008; 23(6):541-6. PubMed ID: 18953221
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effective communication. Interactions with patients with difficulty in communication: an experience in nursing of a patient with scleroderma].
    Fujiaki A; Matsumoto T
    Kurinikaru Sutadi; 1985 Jan; 6(1):49-56. PubMed ID: 3845298
    [No Abstract]   [Full Text] [Related]  

  • 51. Coping strategies for activities of daily living in women whose hands affected by systemic sclerosis.
    Cinar FI; Unver V; Cinar M; Yilmaz S; Simsek I; Tosun N; Erdem H; Yilmaz F; Pay S; Dinc A
    J Clin Nurs; 2014 Jun; 23(11-12):1630-8. PubMed ID: 24330334
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Paediatric morphoea: a holistic review. Part 1: epidemiology, aetiopathogenesis and clinical classification.
    Kaushik A; Mahajan R; De D; Handa S
    Clin Exp Dermatol; 2020 Aug; 45(6):673-678. PubMed ID: 32472964
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Psychosocial Aspects of Scleroderma.
    Kwakkenbos L; Delisle VC; Fox RS; Gholizadeh S; Jewett LR; Levis B; Milette K; Mills SD; Malcarne VL; Thombs BD
    Rheum Dis Clin North Am; 2015 Aug; 41(3):519-28. PubMed ID: 26210133
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [We introduce: self-help group scleroderma. Scleroderma--what is it?].
    Krankenpflege (Frankf); 1987 Apr; 41(4):148. PubMed ID: 3108579
    [No Abstract]   [Full Text] [Related]  

  • 55. Scleroderma--developing measures of response.
    Furst DE; Khanna D; Mattucci-Cerinic M; Silman AJ; Merkel PA; Foeldvari I;
    J Rheumatol; 2005 Dec; 32(12):2477-80. PubMed ID: 16331791
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Scleroderma in children.
    Black CM
    Adv Exp Med Biol; 1999; 455():35-48. PubMed ID: 10599321
    [No Abstract]   [Full Text] [Related]  

  • 57. [When thinking to scleroderma?].
    Cogan E
    Rev Med Brux; 2007 Sep; 28(4):285-9. PubMed ID: 17958022
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physical burden of symptoms in patients with localized scleroderma and eosinophilic fasciitis.
    Kroft EB; de Jong EM; Evers AW
    Arch Dermatol; 2008 Oct; 144(10):1394-5. PubMed ID: 18936410
    [No Abstract]   [Full Text] [Related]  

  • 59. [The clinical picture of morphea].
    Wojas-Pelc A; Wielowieyska-Szybińska D
    Przegl Lek; 2007; 64(6):438-41. PubMed ID: 18159855
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Classification in systemic sclerosis.
    Johnson SR; Laxer RM
    J Rheumatol; 2006 May; 33(5):840-1. PubMed ID: 16652415
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.